Chemical analytics group LGC has been acquired by private equity firm Bridgepoint from LGV Capital in a deal valuing the company at £257 million.

Chemical analytics group LGC has been acquired by private equity firm Bridgepoint from LGV Capital in a deal valuing the company at £257 million.

Bridgepoint bought LGV’s majority stake, backing the current management team led by chief executive David Richardson.

Richardson says that under LGV Capital’s ownership, LGC made seven bolt-on acquisitions and undertook substantial international expansion.

Ivan Heywood, chief executive of LGV Capital, adds that the group has doubled turnover to £120 million and trebled EBITDA to £20 million during that time.

LGC’s four divisions focus on forensics, laboratory support, food and pesticide testing, and providing niche research services.